抗 VEGF 治疗黄斑新生血管的 4 年预后中病理性和非病理性高度近视的差异.
关键词: Aflibercept Chorioretinal atrophy META-PM study Macular neovascularization Pathologic myopia Ranibizumab
Mesh : Humans Male Female Ranibizumab / administration & dosage therapeutic use Recombinant Fusion Proteins / administration & dosage therapeutic use Receptors, Vascular Endothelial Growth Factor / administration & dosage therapeutic use Aged Vascular Endothelial Growth Factor A / antagonists & inhibitors Retrospective Studies Treatment Outcome Middle Aged Myopia, Degenerative / drug therapy complications Visual Acuity Angiogenesis Inhibitors / therapeutic use administration & dosage Intravitreal Injections Choroidal Neovascularization / drug therapy pathology Retinal Neovascularization / drug therapy pathology
来 源:
DOI:10.1038/s41598-024-64456-z
PDF(Pubmed)